The Stanford Innovative Medicines Accelerator (IMA) is accepting proposals for projects that address two major challenges in small molecule drug discovery: adaptation of lab-grade assays to high- throughput
screening (HTS) formats and optimization of lead compounds into drug prototypes.
Sanofi is awarding $150,000 funding for 1 year for translational research that can contribute to their early-stage pipeline and ultimately benefit patients. Please fill in the Pre-Proposal Submission Word Template before May 24th, 2024.
The Wu Tsai Human Performance Alliance invites proposals on athletic performance, injury prevention, and injury recovery to discover the biological principles that govern optimum performance, from the molecular level to the whole body.
Seeking bold proposals from Stanford faculty of any research or clinical backgrounds with the potential to generate paradigm-shifting insights into healthy brain aging and resilience against cognitive decline, and neurodegenerative disorders.
SCI offers Innovation Awards to support collaborative projects focused on acceleration of basic, translational, clinical and population-based cancer research, and projects focused on cancer care, such as pancreatic, breast and gynecologic cancers.
The School of Medicine Kl2 Mentored Career Development Program is a two-year research program funded by the National Institutes of Health (NIH) and the Stanford Clinical Translational Science Award (CTSA) Program.
c-ShARP welcomes collaborative proposals for instrument acquisitions, programs, or other enhancements to Shared Research Platforms and Shared Facilities. Faculty & staff are welcome to apply for FY25 funding.
